Moreover, recent studies indicating the place of COX-2 inhibitors in cancer chemotherapy and neurological diseases such as Parkinson and Alzheimer’s diseases still continues to attract investigations on the development of COX-2 inhibitors. The gene discussed is PTGS2; the disease is early-onset autosomal dominant Alzheimer disease.